- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms, Castration-Resistant in New Zealand
Total 1258 results
-
NYU Langone HealthCompleted
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Celgene CorporationPrologue Research InternationalTerminated
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Duke UniversityCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage IV Prostate CancerUnited States
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Howard University; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Resurge Therapeutics Inc.RecruitingLower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)New Zealand, Australia
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
National Human Genome Research Institute (NHGRI)Completed
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
Lumicell, Inc.TerminatedProstate Cancer | Neoplasm, ResidualUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminated
-
NYU Langone HealthCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Columbia UniversityGenentech, Inc.TerminatedProstate CancerUnited States
-
Matthew GalskyCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthTrod Medical N.V.CompletedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
NYU Langone HealthTerminated
-
NYU Langone HealthDendreonTerminatedProstate CancerUnited States
-
Weill Medical College of Cornell UniversityTerminatedProstate CancerUnited States
-
Icahn School of Medicine at Mount SinaiTerminatedProstate CancerUnited States
-
St. Luke's-Roosevelt Hospital CenterTerminatedProstate CancerUnited States
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
NYU Langone HealthCompletedProstate CancerUnited States
-
Momotaro-Gene Inc.Icahn School of Medicine at Mount SinaiWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
Xanthus Pharmaceuticals, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Completed
-
Weill Medical College of Cornell UniversityCancer Research & Treatment Fund, IncTerminatedProstate CancerUnited States
-
Ashutosh Kumar TewariOncovir, Inc.Completed